HIGH RATES OF ADHERENCE TO BULEVIRTIDE MONOTHERAPY FOR CHRONIC HEPATITIS DELTA THROUGH 96 WEEKS: RESULTS FROM AN INTERIM ANALYSIS OF THE PHASE 3 STUDY MYR301

被引：0
|
作者：
Aleman, Soo
Wedemeyer, Heiner
Brunetto, Maurizia R.
Blank, Antje
Andreone, Pietro
Bogomolov, Pavel
Chulanov, Vladimir
Mamonova, Nina
Geyvandova, Natalia
Morozov, Viacheslav
Sagalova, Olga
Stepanova, Tatyana V.
Da, Ben
Manuilov, Dmitry
Chee, Grace
Li, Mingyang
Lau, Audrey H.
zur Wiesch, Julian Schulze
Cornberg, Markus
Zeuzem, Stefan
Lampertico, Pietro
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1626
引用
收藏
页码：S1603 / S1604
页数：2
相关论文
共 48 条
  • [1] Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study
    Wedemeyer, Heiner
    Aleman, Soo
    Andreone, Pietro
    Blank, Antje
    Brunetto, Maurizia
    Bogomolov, Pavel
    Chulanov, Vladimir
    Geyvandova, Natalia
    Hilgard, Gudrun
    Mamonova, Nina
    Merle, Uta
    Viacheslav, Morozov
    Sagalova, Olga
    Stepanova, Tatyana
    zur Wiesch, Julian Schulze
    Zotov, Sergey
    Zeuzem, Stefan
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2021, 75 : S294 - S295
  • [2] Bulevirtide Monotherapy at Low and High Dose in Patients With Chronic Hepatitis Delta: 24-Week Interim Data of the Phase 3 MYR301 Study
    Lee, Stacey
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Suri, Vithika
    An, Qi
    Flaherty, John F.
    Osinusi, Anu
    zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S858 - S859
  • [3] Bulevirtide monotherapy at low and high doses in patients with chronic hepatitis delta: 24-week interim data of the Phase 3 MYR301 study
    Freismuth, A.
    Wedemeyer, H.
    Aleman, S.
    Brunetto, M.
    Black, A.
    Andreone, P.
    Bogomolov, P.
    Chulanov, V.
    Mamonova, N.
    Geyvandova, N.
    Morozov, V.
    Sagalova, O.
    Stepanova, T.
    Manuilov, D.
    Suri, V.
    An, Qi
    Flaherty, J. F.
    Osinusi, A.
    Zur Wiesch, J. Schulze
    Cornberg, M.
    Zeuzem, S.
    Lampertico, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 52 - 53
  • [4] Efficacy and safety of BLV monotherapy for chronic hepatitis delta: posttreatment results through 48 weeks after the end of treatment from an interim analysis of a randomised Phase 3 study MYR301
    Aleman, S.
    Brunetto, M.
    Blank, A.
    Andreone, P.
    Bogomolov, P.
    Chulanov, V.
    Mamonova, N.
    Geyvandova, N.
    Morozov, V.
    Sagalova, O.
    Stepanova, T.
    Chee, G. M.
    Mercier, R. C.
    Lichtman, A.
    Manuilov, D.
    Arterburn, S.
    Lau, A. H.
    Osinusi, A.
    Christian-Cox, Flo.
    Duff, F.
    zur Wiesch, J. Schulze
    Cornberg, M.
    Zeuzem, S.
    Wedemeyer, H.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [5] EFFICACY AND SAFETY OF BLV MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: POST TREATMENT RESULTS THROUGH 48 WEEKS AFTER THE END OF TREATMENT FROM AN INTERIM ANALYSIS OF A RANDOMIZED PHASE 3 STUDY MYR301
    Chee, Grace
    Aleman, Soo
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Viacheslav, Morozov
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Arterburn, Sarah
    Lau, Audrey
    Osinusi, Anu
    Christian-Cox, Florence
    Duff, Frank
    Zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Wedemeyer, Heiner
    Lampertico, Pietro
    HEPATOLOGY, 2024, 80 : S107 - S108
  • [6] Efficacy and safety of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis delta at 96 weeks: Results from an interim analysis of a phase 3 randomized study
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Freismuth, Aurelie
    Flaherty, John F.
    Osinusi, Anu
    Lau, Audrey
    Wiesch, Julian Schulze Zur
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 101 - 102
  • [7] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDY
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Flaherty, John
    Osinusi, Anu
    Lau, Audrey
    zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    GUT, 2023, 72 (SUPPL_3) : A103 - A104
  • [8] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDY
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia R.
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana V.
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Flaherty, John F.
    Osinusi, Anu
    Lau, Audrey H.
    Wiesch, Julian Schulze zur
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    GASTROENTEROLOGY, 2024, 166 (05) : S1600 - S1600
  • [9] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDY
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Flaherty, John
    Osinusi, Anu
    Lau, Audrey
    zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    GUT, 2023, 72 : A103 - A104
  • [10] Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide
    Buti, Maria
    Wedemeyer, Heiner
    Aleman, Soo
    Chulanov, Vladimir
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatiana
    Gish, Robert G.
    Lloyd, Andrew
    Kaushik, Ankita M.
    Suri, Vithika
    Manuilov, Dmitry
    Osinusi, Anu O.
    Flaherty, John F.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2025, 82 (01)
12345